miR-650 Promotes the Metastasis and Epithelial –Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression

Conclusion: In conclusion, the miR-650/LATS2 pathway may serve as a novel prognostic biomarker and an attractive therapeutic target for HCC patients.Cell Physiol Biochem 2018;51:1179 –1192
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research